Innovent's Shares Surge Following First Annual Profit Announcement

Innovent Biologics experienced its largest share increase in almost five months after reporting its first annual profit. Bloomberg posted on X, highlighting that the Chinese pharmaceutical company attributed this financial success to the rising demand for its weight-loss medication. The positive financial results have significantly boosted investor confidence, leading to a notable rise in the company's stock value.